TG THERAPEUTICS, INC. Money Market Funds, at Carrying Value
TG THERAPEUTICS, INC. (TGTX) had Money Market Funds, at Carrying Value of $153.56 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2021-03-01
- 2020-12-31: Money Market Funds, at Carrying Value $153.56M.
- 2020-09-30: Money Market Funds, at Carrying Value $30.54M.
- 2020-06-30: Money Market Funds, at Carrying Value $15.46M.
- 2020-03-31: Money Market Funds, at Carrying Value $4.15M.
| Period end | Money Market Funds, at Carrying Value | Money Market Funds, at Carrying Value as first filed |
|---|---|---|
| 2020-12-31 | $153.56M 10-K · filed 2021-03-01 | |
| 2020-09-30 | $30.54M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $15.46M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.15M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.50M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $2.37M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.23M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.68M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $2.69M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $2.37M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $8.68M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.97M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.04M 10-K · filed 2019-03-01 | $1.04M 10-K · filed 2018-03-15 |
| 2017-09-30 | $29.06M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $20.15M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $15.11M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $20.98M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $24.32M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $8.51M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.84M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $8.27M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $5.63M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.27M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $16.30M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $12.36M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $6.45M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.36M 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $15.59M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $554.07K 10-K · filed 2015-03-16 | |
| 2012-12-31 | $500.01K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |